QA: Orgenesis Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2019_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 30,297,000
1 IntangibleAssetsNetIncludingGoodwill 31,865,000
2 PropertyPlantAndEquipmentNet 11,901,000
3 remainder_Assets 1,384,000
4 LiabilitiesCurrent 17,145,000
5 LiabilitiesNoncurrent 5,500,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 12,287,390
8 SellingGeneralAndAdministrativeExpense 51,847,999
9 ResearchAndDevelopmentExpense 26,216,372
10 remainder_Expenses 17,831,099
11 remainder_Revenues 79,025,812
12 remainder_NetIncome -3,886,285
13 remainder_ComprehensiveNetIncome 861,869
  yvar yval
0 Assets 75,447,000
1 Liabilities 22,645,000
2 Expenses 108,182,860
3 Revenues 79,025,812
4 StockholdersEquity 52,802,000
5 NetIncome -33,043,333
6 ComprehensiveNetIncome -32,612,398
7 BaseVar 145,024,413
8 EconomicCapitalRatiobeforeLimitedLiability 1.68
9 EconomicCapitalRatio 2.81

Edgar->Model Mapping

Feature Distribution

Change over Time